Latest Lead News

Kincora Copper has been awarded a $143,483 drilling grant from the NSW Government to advance exploration at its promising Wongarbon porphyry project, marking a key step in unlocking one of Australia’s significant copper-gold prospects.

Service Stream has delivered a robust FY25 performance with revenue growth, record profits, and a landmark $1.6 billion Defence contract, setting the stage for continued expansion.

Barton Gold Holdings has secured $15 million through an institutional placement led by Franklin Templeton, with a $2.5 million Share Purchase Plan opening to shareholders. The capital raise supports the company’s goal to commission Stage 1 production by the end of 2026 in South Australia’s Gawler Craton.

Westar Resources has secured $1.5 million through a heavily discounted share placement aimed at funding exploration and new project due diligence. The capital raise involves issuing 300 million shares, including participation from company directors.

Adairs Limited has updated its first half FY26 sales and gross margin guidance, reflecting moderated growth and mixed brand performances as it prepares for a critical peak trading period.

Alvo Minerals advances exploration at its Palma Copper-Zinc Project in Brazil, identifying several new high-priority prospects ready for drilling. The project already hosts a substantial 7.6Mt JORC resource, with ongoing work aiming to expand this base.

4DMedical secures a major commercial breakthrough with Stanford University adopting its FDA-cleared CT, VQ™ technology, while its partnership with AstraZeneca rapidly scales lung screening across Brazil.

TrivarX has completed recruitment of 60 patients in its US veteran-focused mental health trial, advancing validation of its novel single-lead ECG algorithm for depression screening. Positive interim results from 27 patients set the stage for full data release and commercial discussions.

Pinnacle Investment Management has secured a strategic foothold in Japan’s private markets by acquiring up to 13% of Advantage Partners, complementing its strong FY25 growth and global expansion ambitions.

Noxopharm Limited has been granted its first US patent for the Sofra™ technology platform, marking a key milestone in its cancer immunotherapy research. This patent protects the company’s innovative immune-modulatory oligonucleotides, underpinning its expanding pipeline in a rapidly growing market.

Vitrafy Life Sciences has delivered its first production unit of the next-generation cryopreservation device, advanced its US commercial footprint, and maintained a strong financial position heading into FY2026.

Comms Group Limited reported a steady 2% revenue increase in FY25, hitting the highest gross margin in five years, while targeting over $75 million in run-rate revenue post-TasmaNet integration.